Sertralinum

Readily available Recent EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 50 mg Tablets

Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Central nervous system
- Mental Health

Action: Antidepressants (CNS)

Full Description:
Sertralinum dossier:
-New readily available for licensing
-Marketing Authorization to be obtained in The Netherlands (we can also register in other countries)
-Stability: 25°C: 24 months + continued, 40°C: 6 months

Availability and Market information:

Status: Registration

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Netherlands : 2001
Registration info: On request: registration in other countries

Market information

Other Market Info:

Patent Information:
Name: Serlain = Lustral
Patent expiration date: 2005
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.